Xenetic Biosciences Adjourns 2025 Annual Stockholders Meeting

Xenetic Biosciences, Inc. (NASDAQ: XBIO) has announced the adjournment of its 2025 Annual Meeting of Stockholders due to a lack of quorum. The meeting was initially scheduled to conduct business, but fewer than the majority of shares entitled to vote were present. Consequently, the meeting had to be adjourned to allow more time for gathering votes. The reconvened meeting is set for January 8, 2026, and will remain a virtual event.

Stockholders who have already submitted their votes do not need to re-vote; their existing votes will count at the reconvened meeting unless formally revoked. Shareholders of record as of October 15, 2025, are encouraged to cast their votes online or via telephone before January 7, 2026. Details and instructions are available through www.proxyvote.com and the company's website at www.xeneticbio.com.